ES549534A0 - Procedimiento para la preparacion de sales del acido d-6 me-toxi-alfametil-2-naftalenacetico - Google Patents

Procedimiento para la preparacion de sales del acido d-6 me-toxi-alfametil-2-naftalenacetico

Info

Publication number
ES549534A0
ES549534A0 ES549534A ES549534A ES549534A0 ES 549534 A0 ES549534 A0 ES 549534A0 ES 549534 A ES549534 A ES 549534A ES 549534 A ES549534 A ES 549534A ES 549534 A0 ES549534 A0 ES 549534A0
Authority
ES
Spain
Prior art keywords
naftalenacetico
alfametil
toxi
salts
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549534A
Other languages
English (en)
Other versions
ES8701146A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Biochimico Pavese Pharma SpA
Original Assignee
Istituto Biochimico Pavese Pharma SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Biochimico Pavese Pharma SpA filed Critical Istituto Biochimico Pavese Pharma SpA
Publication of ES549534A0 publication Critical patent/ES549534A0/es
Publication of ES8701146A1 publication Critical patent/ES8701146A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES549534A 1984-12-05 1985-12-03 Procedimiento para la preparacion de sales del acido d-6 me-toxi-alfametil-2-naftalenacetico Expired ES8701146A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23897/84A IT1196356B (it) 1984-12-05 1984-12-05 Sale solubile avente attivita' anti-infiammatoria,procedimento per la sua preparazione e forme farmaceutiche contenenti lo stesso

Publications (2)

Publication Number Publication Date
ES549534A0 true ES549534A0 (es) 1986-12-01
ES8701146A1 ES8701146A1 (es) 1986-12-01

Family

ID=11210728

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549534A Expired ES8701146A1 (es) 1984-12-05 1985-12-03 Procedimiento para la preparacion de sales del acido d-6 me-toxi-alfametil-2-naftalenacetico

Country Status (8)

Country Link
US (1) US4672077A (es)
JP (1) JPS62286956A (es)
BE (1) BE903785A (es)
CH (1) CH663783A5 (es)
DE (1) DE3542906C2 (es)
ES (1) ES8701146A1 (es)
FR (1) FR2574076B1 (es)
IT (1) IT1196356B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297126A (es) * 1962-08-28

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2794045A (en) * 1953-11-09 1957-05-28 Beaufour Henri Monobetaine citrate
US3002886A (en) * 1958-03-03 1961-10-03 Synergistics Inc Betaine salicylates and the method for their preparation
DE1195767B (de) * 1961-01-10 1965-07-01 Mundipharma Ag Verfahren zur Herstellung eines therapeutisch verwendbaren Salicylsaeuresalzes
GB950505A (en) * 1961-01-10 1964-02-26 Mundipharma Ag Improvements in betaine salicylates and the method for their preparation
FR1391M (fr) * 1961-07-01 1962-07-09 Jacques Emile Cailliot 1-bromo 2-hydroxy 3-naphtoate de bétaine.
US3242048A (en) * 1962-06-20 1966-03-22 Synergistics Inc Betaine glutamate and methods of using same
FR1479304A (fr) * 1966-02-16 1967-05-05 Sapchim Fournier Cimag Soc Nouveaux dérivés aminés de l'acide gentisique et procédés de fabrication
BR6915470D0 (pt) * 1969-03-24 1973-03-13 Syntex Corp Processo para preparar derivados de acido 2-(6'substituido 2'naftil)propionico e de seus sais
GB1497044A (en) * 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US4080472A (en) * 1974-03-22 1978-03-21 Societe D'etudes Et D'exploitation De Marques Et Brevets S.E.M.S. Metformin 2-(p-chlorophenoxy)-2-methylpropionate
DE2935776A1 (de) * 1979-09-05 1981-04-16 Theodor Prof. Dr. 4400 Münster Eckert Organische salze des indometacin, des naproxen und des diclofenac, ihre herstellung und sie enthaltende arzneimittel

Also Published As

Publication number Publication date
US4672077A (en) 1987-06-09
DE3542906A1 (de) 1986-06-12
FR2574076A1 (fr) 1986-06-06
CH663783A5 (it) 1988-01-15
JPS62286956A (ja) 1987-12-12
ES8701146A1 (es) 1986-12-01
FR2574076B1 (fr) 1989-07-28
BE903785A (fr) 1986-04-01
IT8423897A0 (it) 1984-12-05
DE3542906C2 (de) 1995-06-14
IT1196356B (it) 1988-11-16

Similar Documents

Publication Publication Date Title
MX156874A (es) Un procedimiento para la preparacion de un diesterasimetrico del acido 1,4-dihidro-2,6-dimetilpiridin-3,5-dicarboxilico
ES549929A0 (es) Procedimiento para la produccion de acido tereftalico
ES549359A0 (es) Un procedimiento para la preparacion de nuevos derivados del acido (5-amino-2-hidroxi)benzoico.
ES507811A0 (es) Procedimiento para preparar sales de acido 5,5'-azobis-salicico.
ES533495A0 (es) Procedimiento para la preparacion de derivados del acido oxamidico
AR225363A1 (es) Procedimiento para la preparacion de acido alfa-hidroxi-gamma-metilmercaptobutirico
AR230056A1 (es) Procedimiento para la preparacion de derivados del acido 3-ridilmetilo 3-piridilmetilo 3-inidazolilmetil indolil-acrilico
ES518137A0 (es) Procedimiento para la preparacion de n-piridil-amidas de acido 1-fenil-ciclopentancarboxilico.
ES549677A0 (es) Procedimiento para la preparacion de derivados de acidos 1- fenil-imidazol-5-carboxilicos
ES535000A0 (es) Procedimiento para la preparacion de derivados de acido piridacinilcarboxilico
ES538029A0 (es) Procedimiento para la preparacion de derivados del acido indolacetico
ES492243A0 (es) Procedimiento para la preparacion de acido 4,4'dinitro es- tilben-2,2'-disulfonico y sus sales
ES552061A0 (es) Un procedimiento para la preparacion de derivados del acido fenilnonatetraenoico
ES538906A0 (es) Un procedimiento para la preparacion de nuevos derivados del acido tiazolilacetico.
ES549534A0 (es) Procedimiento para la preparacion de sales del acido d-6 me-toxi-alfametil-2-naftalenacetico
ES548435A0 (es) Procedimiento para la obtencion de acido (5,r 6s)-2-aminome-til-6-(1r)-1-hidroxietil -2-penem-3-carboxilico cristalino
MX156980A (es) Procedimiento para la produccion de acido p-nitrotoluen-2-sulfonico
ES543251A0 (es) Procedimiento para la fabricacion de acido fluorhidrico
ES545068A0 (es) Procedimiento para la fabricacion de derivados del acido aminotiazolilpropandicarboxilico
ES540832A0 (es) Procedimiento para preparar acido tereftalico
ES545632A0 (es) Procedimiento para la preparacion de derivados eterificados de acido hidroxialquilfosfonico
ES546667A0 (es) Procedimiento para preparar acido glioxilico
ES545118A0 (es) Procedimiento para la preparacion del acido 3-acetoximetil- 7--2-(2-aminotiazolil-4)-2-sin-metoxiimino-acetamido-3- cefem-4-carboxilico
ES547824A0 (es) Procedimiento para la preparacion y purificacion de sales del acido noramidopiriniometansulfonico
AR240919A1 (es) Procedimiento para la prepararacion de derivados del acido quinolin-car-boxilico.